345 related articles for article (PubMed ID: 29033215)
1. Treating resistant Pseudomonas aeruginosa lung disease in young children with cystic fibrosis.
Lim SZP; Fitzgerald DA
Paediatr Respir Rev; 2018 Jun; 27():33-36. PubMed ID: 29033215
[TBL] [Abstract][Full Text] [Related]
2. Multi-resistant Pseudomonas aeruginosa ST235 in cystic fibrosis.
Lee AC; Jones AL
Paediatr Respir Rev; 2018 Jun; 27():18-20. PubMed ID: 29914746
[TBL] [Abstract][Full Text] [Related]
3. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
Banerjee D; Stableforth D
Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of resistant Pseudomonas aeruginosa with elective and rescue intravenous antibiotic regimens in children with cystic fibrosis.
Smyth E; David TJ; Patel L; Ashcroft P; Sanyal D; Vyas J
Int J Antimicrob Agents; 2005 Jul; 26(1):95-6. PubMed ID: 15970432
[No Abstract] [Full Text] [Related]
5. Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains.
Varga JJ; Barbier M; Mulet X; Bielecki P; Bartell JA; Owings JP; Martinez-Ramos I; Hittle LE; Davis MR; Damron FH; Liechti GW; Puchałka J; dos Santos VA; Ernst RK; Papin JA; Albertí S; Oliver A; Goldberg JB
BMC Genomics; 2015 Oct; 16():883. PubMed ID: 26519161
[TBL] [Abstract][Full Text] [Related]
6. Diversification of Pseudomonas aeruginosa within the cystic fibrosis lung and its effects on antibiotic resistance.
Clark ST; Guttman DS; Hwang DM
FEMS Microbiol Lett; 2018 Mar; 365(6):. PubMed ID: 29401362
[TBL] [Abstract][Full Text] [Related]
7. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.
Taccetti G; Campana S; Festini F; Mascherini M; Döring G
Eur Respir J; 2005 Sep; 26(3):458-61. PubMed ID: 16135728
[TBL] [Abstract][Full Text] [Related]
8. Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis.
Evans TJ
Future Microbiol; 2015; 10(2):231-9. PubMed ID: 25689535
[TBL] [Abstract][Full Text] [Related]
9. Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa.
Beringer PM; Bensman TJ; Ho H; Agnello M; Denovel N; Nguyen A; Wong-Beringer A; She R; Tran DQ; Moskowitz SM; Selsted ME
J Antimicrob Chemother; 2016 Jan; 71(1):181-8. PubMed ID: 26433781
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas colonization in cystic fibrosis. A study of 160 patients.
Kulczycki LL; Murphy TM; Bellanti JA
JAMA; 1978 Jul; 240(1):30-4. PubMed ID: 96277
[TBL] [Abstract][Full Text] [Related]
11. Levofloxacin inhalation solution for the treatment of chronic Pseudomonas aeruginosa infection among patients with cystic fibrosis.
Stockmann C; Hillyard B; Ampofo K; Spigarelli MG; Sherwin CM
Expert Rev Respir Med; 2015 Feb; 9(1):13-22. PubMed ID: 25417708
[TBL] [Abstract][Full Text] [Related]
12. INCREASING BURDEN OF ANTIMICROBIAL RESISTANCE IN
Gramegna A; Moore JE; McCaughan J; Millar BC; Ewing J; Elborn JS; Blasi F; Downey DG
Ulster Med J; 2018 May; 87(2):129-130. PubMed ID: 29867273
[No Abstract] [Full Text] [Related]
13. Eradication of Pseudomonas aeruginosa in cystic fibrosis.
Eber E; Thalhammer GH; Zach MS
Eur Respir J; 2006 Feb; 27(2):438-9. PubMed ID: 16452606
[No Abstract] [Full Text] [Related]
14. Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic Fibrosis.
Ang JY; Abdel-Haq N; Zhu F; Thabit AK; Nicolau DP; Satlin MJ; van Duin D
Antimicrob Agents Chemother; 2016 Oct; 60(10):5627-30. PubMed ID: 27664282
[TBL] [Abstract][Full Text] [Related]
15. Pseudomonas infections in cystic fibrosis.
George RH
Arch Dis Child; 1987 May; 62(5):438-9. PubMed ID: 3111389
[No Abstract] [Full Text] [Related]
16. Blocking RpoN reduces virulence of Pseudomonas aeruginosa isolated from cystic fibrosis patients and increases antibiotic sensitivity in a laboratory strain.
Lloyd MG; Vossler JL; Nomura CT; Moffat JF
Sci Rep; 2019 Apr; 9(1):6677. PubMed ID: 31040330
[TBL] [Abstract][Full Text] [Related]
17. Bacteriological effects of anti-Pseudomonas aeruginosa chemotherapy in cystic fibrosis.
Bauernfeind A; Emminger G; Hörl G; Ott S; Przyklenk B; Weisslein-Pfister C
Infection; 1987; 15(5):403-6. PubMed ID: 3121519
[TBL] [Abstract][Full Text] [Related]
18. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R
Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960
[TBL] [Abstract][Full Text] [Related]
19. Characterization by phenotypic and genotypic methods of metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
Li Y; Zhang X; Wang C; Hu Y; Niu X; Pei D; He Z; Bi Y
Mol Med Rep; 2015 Jan; 11(1):494-8. PubMed ID: 25323940
[TBL] [Abstract][Full Text] [Related]
20. [Antibiotic therapy against Pseudomonas aeruginosa and other gram-negative bacteria in cystic fibrosis].
Le Bourgeois M
Arch Pediatr; 2003 Sep; 10 Suppl 2():352s-357s. PubMed ID: 14671934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
